HealthEquity (NASDAQ:HQY) Stock Rating Raised to Buy at Wall Street Zen

Wall Street Zen upgraded shares of HealthEquity (NASDAQ:HQY) from a hold rating to a buy rating in a report published on Saturday,Wall Street Zen reports.

Several other equities analysts have also recently issued reports on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Raymond James Financial reaffirmed a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd. Weiss Ratings downgraded shares of HealthEquity from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Barclays boosted their price target on shares of HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, September 18th. Finally, Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research report on Friday, August 28th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $112.20.

HealthEquity Stock Performance

NASDAQ:HQY opened at $92.61 on Friday. HealthEquity has a 52 week low of $72.76 and a 52 week high of $107.62. The company has a fifty day simple moving average of $97.38 and a two-hundred day simple moving average of $91.09. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. The company has a market cap of $7.66 billion, a price-to-earnings ratio of 33.43, a price-to-earnings-growth ratio of 1.46 and a beta of 0.24.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The business had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity’s revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities analysts anticipate that HealthEquity will post 3.93 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director directly owned 62,395 shares of the company’s stock, valued at $6,527,140.95. The trade was a 10.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Oxbow Advisors LLC acquired a new stake in HealthEquity in the first quarter valued at about $3,147,000. Maridea Wealth Management LLC purchased a new stake in HealthEquity in the 2nd quarter valued at approximately $2,753,000. Deutsche Bank AG acquired a new position in HealthEquity during the 2nd quarter worth approximately $11,986,000. Amundi increased its position in HealthEquity by 33.6% during the 2nd quarter. Amundi now owns 90,327 shares of the company’s stock worth $8,158,000 after purchasing an additional 22,735 shares during the period. Finally, Bamco Inc. NY purchased a new position in shares of HealthEquity during the 2nd quarter worth approximately $67,776,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) provides technology-enabled services for consumer-directed health and benefits accounts. The company administers health savings accounts (HSAs) and offers related products such as flexible spending accounts, health reimbursement arrangements, commuter benefits and other employee benefit programs.

Its platform is designed to help employers, benefits advisors, health plans and individuals manage benefits, make healthcare payments, access account information and invest eligible HSA funds.